Prothena directors/officers adopt 10b5-1 plans for 458,174 expiring options

PROTHENA CORP PUBLIC LTD CO

Options granted in Jan/Mar/Apr 2013 expire in Jan/Mar/Apr 2023; cover 458,174 shares (<1% of outstanding) with exercise prices $6.41-$6.73 per share.
Directors and executive officers adopted Rule 10b5-1 trading plans to exercise/sell these expiring options.
Plans allow orderly disposition of options expiring in 2023; transactions will be reported to the SEC.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.